164 related articles for article (PubMed ID: 34748524)
1. Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis.
Qiu J; Tao ZC; Deng KX; Wang P; Chen CY; Xiao F; Luo Y; Yuan SY; Chen H; Huang H
Chin Med J (Engl); 2021 Oct; 134(21):2535-2543. PubMed ID: 34748524
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.
Wan B; Wang S; Tu M; Wu B; Han P; Xu H
Medicine (Baltimore); 2017 Mar; 96(11):e6333. PubMed ID: 28296759
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of diffusion-weighted imaging in differentiating glioma recurrence from posttreatment-related changes: a meta-analysis.
Du X; He Q; Zhang B; Li N; Zeng X; Li W
Expert Rev Anticancer Ther; 2022 Jan; 22(1):123-130. PubMed ID: 34727815
[TBL] [Abstract][Full Text] [Related]
5. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
Zhang J; Wang Y; Wang Y; Xiao H; Chen X; Lei Y; Feng Z; Ma X; Ma L
Quant Imaging Med Surg; 2022 Oct; 12(10):4805-4822. PubMed ID: 36185045
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for breast cancer detection: An update meta-analysis.
Dong H; Kang L; Cheng S; Zhang R
Thorac Cancer; 2021 Dec; 12(23):3201-3207. PubMed ID: 34668649
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiation Between Recurrence and Pseudoprogression in High-Grade Glioma: A Meta-analysis.
Gu X; He X; Wang H; Li J; Chen R; Liu H
J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):303-310. PubMed ID: 37654056
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.
Okuchi S; Rojas-Garcia A; Ulyte A; Lopez I; Ušinskienė J; Lewis M; Hassanein SM; Sanverdi E; Golay X; Thust S; Panovska-Griffiths J; Bisdas S
Cancer Med; 2019 Sep; 8(12):5564-5573. PubMed ID: 31389669
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis on the diagnostic value of laser Doppler imaging for burn depth].
Huang Y; Qiu L; Mei AL; Li JX
Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):301-308. PubMed ID: 28651422
[No Abstract] [Full Text] [Related]
11. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis.
Ouyang ZQ; Zheng GR; Duan XR; Zhang XR; Ke TF; Bao SS; Yang J; He B; Liao CD
Quant Imaging Med Surg; 2023 Aug; 13(8):4943-4959. PubMed ID: 37581048
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis.
Xuan M; Zhou F; Ding Y; Zhu Q; Dong J; Zhou H; Cheng J; Jiang X; Wu P
Surg Endosc; 2018 Apr; 32(4):2067-2075. PubMed ID: 29270801
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies.
Yu T; Meng N; Chi D; Zhao Y; Wang Z; Luo Y
Cell Biochem Biophys; 2015 Jul; 72(3):687-94. PubMed ID: 27352188
[TBL] [Abstract][Full Text] [Related]
16. Diffusion kurtosis imaging combined with dynamic susceptibility contrast-enhanced MRI in differentiating high-grade glioma recurrence from pseudoprogression.
Shi W; Qu C; Wang X; Liang X; Tan Y; Zhang H
Eur J Radiol; 2021 Nov; 144():109941. PubMed ID: 34735828
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis.
Wei M; Bo F; Cao H; Zhou W; Shan W; Bai G
Acta Radiol; 2021 Jul; 62(7):966-978. PubMed ID: 32741199
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic accuracy of artery peak velocity variation measured by bedside real-time ultrasound for prediction of fluid responsiveness: a Meta-analysis].
Pei Y; Yang Y; Feng Y; He S; Zhou J; Jiang H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):99-105. PubMed ID: 32148240
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and grading accuracy of
Xiao J; Jin Y; Nie J; Chen F; Ma X
BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
